Trial Profile
Treatment of equinus gait caused by dynamic tightening of the calf muscles in children with cerebral palsy. A randomized, placebo controlled Botulinum toxin type A volume/response study.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 27 Oct 2017
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Neurologic gait disorders
- Focus Therapeutic Use
- 26 Oct 2017 Status changed from recruiting to discontinued.
- 07 Dec 2016 New trial record